Pfenex (PFNX) Tops Q1 EPS by 10c

Pfenex (NYSE: PFNX) reported Q1 EPS of ($0.35), $0.10 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $2.76 million versus the consensus estimate of $2.35 million.

For earnings history and earnings-related data on Pfenex (PFNX) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18